Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice : a randomized, open-label, parallel-group, multi-center study : the DISCOVERY-beta study
autor
vastutusandmed
Toivo Laks, Ester Keba, Mariann Leiner, Eero Merilind, Mall Petersen, Sirje Reinmets, Sille Väli, Terje Sööt, Karin Otter
allikas
Vascular health and risk management
ajakirja aastakäik number kuu
4
ilmumisaasta
leheküljed
6, p. 1147-1156
märksõna
tolerantsus (bioloogia)
ISSN
1176-6344
keel
inglise
Laks, T., Keba, E., Leiner, M., Merilind, E., Petersen, M., Reinmets, S., Väli, S., Sööt, T., Otter, K. Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice : a randomized, open-label, parallel-group, multi-center study : the DISCOVERY-beta study // Vascular health and risk management (2008) 4, 6, p. 1147-1156. https://pubmed.ncbi.nlm.nih.gov/19337553/